Recordati acquires Yeni Ilac of Turkey
This article was originally published in Scrip
Executive Summary
Recordati, the Italian company with particular interests in cardiovascular and urogenital therapeutics, has acquired Yeni Ilac, an Istanbul-based pharmaceutical company, for €48 million. The transaction is subject to clearance by competition authorities and is expected to be closed by the end of this year.